Featured Research

from universities, journals, and other organizations

59-Year-Old Man Doing Well After Rare Simultaneous Liver Transplant/Coronary Bypass Surgery

Date:
June 10, 1998
Source:
University Of Illinois At Chicago
Summary:
A 59-year-old patient who underwent a rare simultaneous liver transplant and coronary artery bypass operation a year ago at the University of Illinois at Chicago Medical Center is doing extremely well. His case was featured in a recent issue of the Annals of Thoracic Surgery.

A year ago, 59-year-old Anthony Capua underwent a double liver transplant-coronary bypass through a pioneering procedure at the University of Illinois at Chicago.

Related Articles


Capua is living a normal life and enjoying his retirement.

Done separately, either operation probably would have failed and he would not have survived. After doctors at two Chicago hospitals told him it was impossible to perform the two procedures simultaneously, two University of Illinois at Chicago physicians operated successfully on June 19, 1997.

The La Grange, Ill., resident had been on a waiting list for two months before a suitable liver became available.Surgeon Malek Massad did the bypass first. Then, with Capua's heart once again functioning normally, his colleague Enrico Benedetti replaced his damaged liver.

Only two successful simultaneous coronary artery bypass graftings and orthotopic liver transplantations have been reported in medical literature. But Benedetti believes there will be more as older people at risk for coronary artery disease are evaluated for transplants.

"Forty percent of liver transplants are done on people above 50," he said. "Consequently, more of those people are likely to have coronary artery disease. If you do the transplant without fixing the heart, the patient will die of a heart attack. But you can't fix the heart because of the severe liver failure."

Advanced coronary artery disease has traditionally been considered an absolute contraindication to liver transplantation, the surgeons wrote in a paper about the procedure in the April 1998 Annals of Thoracic Surgery. Chronic liver failure significantly increases the risk for coronary artery bypass surgery, they added.

"The presence of advanced coronary artery disease in a candidate for liver transplantation should not be considered an absolute contraindication to transplant," they said. "In selected cases, performing a simultaneous coronary artery bypass and liver transplantation may provide an ideal treatment for both life-threatening diseases." Considering Capua's active life a year after the surgery, "the outcome has proven we were right," Benedetti said.

The surgical team plans to perform the same procedure on two more patients at UIC as soon as donor livers become available.


Story Source:

The above story is based on materials provided by University Of Illinois At Chicago. Note: Materials may be edited for content and length.


Cite This Page:

University Of Illinois At Chicago. "59-Year-Old Man Doing Well After Rare Simultaneous Liver Transplant/Coronary Bypass Surgery." ScienceDaily. ScienceDaily, 10 June 1998. <www.sciencedaily.com/releases/1998/06/980610211450.htm>.
University Of Illinois At Chicago. (1998, June 10). 59-Year-Old Man Doing Well After Rare Simultaneous Liver Transplant/Coronary Bypass Surgery. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/1998/06/980610211450.htm
University Of Illinois At Chicago. "59-Year-Old Man Doing Well After Rare Simultaneous Liver Transplant/Coronary Bypass Surgery." ScienceDaily. www.sciencedaily.com/releases/1998/06/980610211450.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins